Comparison of cocaine- and methamphetamine-evoked dopamine and glutamate overflow in somatodendritic and terminal field regions of the rat brain during acute, chronic, and early withdrawal conditions

Annals of the New York Academy of Sciences

Volumn 937, Issue , 2001, Pages 93-120

  Zhang, Yong ^a   Loonam, Thomas M ^a   Noailles, Pierre A H ^a   Angulo, Jesus A ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Caudate putame; Cocaine; Dopamine; Glutamate; Methamphetamine; Nucleus accumbens; Substantia nigra compacta; Ventral tegmental area

Indexed keywords

AMPHETAMINE DERIVATIVE; COCAINE; DOPAMINE; GLUTAMIC ACID; METHAMPHETAMINE; NEUROTRANSMITTER; PSYCHOSTIMULANT AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BEHAVIOR MODIFICATION; BRAIN REGION; CONFERENCE PAPER; DRUG ACCUMULATION; DRUG EXPOSURE; DRUG WITHDRAWAL; EXTRACELLULAR SPACE; LOCOMOTION; MALE; NEOSTRIATUM; NONHUMAN; NUCLEUS ACCUMBENS; PUTAMEN; RAT; SENSITIZATION; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

ANIMALIA;

EID: 0034972478     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb03560.x     Document Type: Conference Paper

References (78)

1. Dual effects of D-amphetamine on dopamine neurons mediated by dopamine and nondopamine receptors
2. Firing rate of nucleus accumbens neurons is dopamine-dependent and reflects the timing of cocaine-seeking behavior in rats on a progressive ratio schedule of reinforcement
3. The pharmacological and anatomical substrates of the amphetamine response in the rat
4. Selective 6-OHDA-induced destruction of mesolimbic dopamine neurons: Abolition of psychostimulant-induced locomotor activity in rats
5. Cocaine: Discussion on the role of dopamine in the biochemical mechanism of action
6. Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens
7. Microinjections of Sch-23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systemic amphetamine
8. Behavioral sensitization is accompanied by an enhancement in amphetamine-stimulated dopamine release from striatal tissue in vitro
9. Time course of the development of the enhanced behavioral and biochemical responses to amphetamine after pretreatment with amphetamine
10. The long-term effects of repeated amphetamine treatment in vivo on amphetamine, KCl and electrical stimulation evoked striatal dopamine release in vitro
11. Enhancement of dopamine release from striatal slices of rats that were subchronically treated with methamphetamine
12. Effects of daily cocaine and morphine treatment on somatodendritic and terminal field dopamine release
13. Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)- amphetamine: A microdialysis study in freely moving rats
14. Subchronic cocaine treatment enhances cocaine-induced dopamine efflux, studied by in vivo intracerebral dialysis
15. Effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens
16. Extracellular concentrations of cocaine and dopamine are enhanced during chronic cocaine administration
17. Cocaine reinforcement and extracellular dopamine overflow in rat nucleus accumbens: An in vivo microdialysis study
18. In vivo microdialysis reveals a diminished amphetamine-induced DA response corresponding to behavioral sensitization produced by repeated amphetamine pretreatment
19. Repeated cocaine administration induces behavioral sensitization and corresponding decreased extracellular dopamine responses in caudate and accumbens
20. Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals
21. Time course of extracellular dopamine and behavioral sensitization to cocaine. II. Dopamine perikarya
22. Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum
23. Chronic D-amphetamine in nucleus accumbens: Lack of tolerance or reverse tolerance of locomotor activity
24. Amphetamine injection into the ventral mesencephalon sensitizes rats to peripheral amphetamine and cocaine
25. Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine: Lack of conditioned effects
26. DNQX blockade of amphetamine behavioral sensitization
27. Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine
28. Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist, MK-801
29. Neurophysiological alterations in the mesocorticolimbic dopamine system with repeated cocaine administration
30. MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine
31. Cortico-striate interrelations in the albino rat
32. The thalamostriatal projection in the cat
33. The neostriatal mosaic: Compartmentalization of corticostriatal input and striatonigral output systems
34. Origins of postsynaptic potentials evoked in identified rat neostriatal neurons by stimulation in substantia nigra
35. Origins of post synaptic potentials evoked in spiny neostriatal projection neurons by thalamic stimulation in the rat
36. Characterization of L-glutamate action on the release of endogenous dopamine from the rat caudate-putamen
37. Metabotropic glutamate receptor activation produces extrapyramidal motor system activation that is mediated by striatal dopamine
38. Glutamate modulates dopamine release in the striatum as measured by brain microdialysis
39. Presynaptic glutamate receptors modulate dopamine release from striatal synaptosomes
40. D1 receptors modulate glutamate transmission in the ventral tegmental area
41. Glutamatergic control of dopamine release during stress in the rat prefrontal cortex
42. Glutamate in cortical fibers
43. Glutamate release in vitro from corticostriatal terminals
44. Antagonism of cortical excitation of striatal neurons by glutamic acid diethyl ester: Evidence for glutamic acid as an excitatory transmitter in the rat striatum
45. Postsynaptic integration of glutamatergic and dopaminergic signals in the striatum
46. The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones
47. The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice
48. Topographical distribution of possible glutamatergic pathways from the frontal cortex to the striatum and substantia nigra in rats
49. Burst firing induced in midbrain dopamine neurons by stimulation of the medial prefrontal and anterior cingulate cortices
50. Iontophoretically administered drugs acting at the N-methyl-D-aspartate receptor modulate burst firing in A9 dopamine neurons in the rat
51. Burst firing in dopamine neurons induced by N-methyl-D-aspartate: Role of electrogenic sodium pump
52. Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electro-chemistry
53. Relationship between dopamine release in the rat nucleus accumbens and the discharge activity of dopaminergic neurons during local in vivo application of amino acids in the ventral tegmental area
54. 3H]aminobutyric acid release?
55. Synergistically interacting dopamine D1 and NMDA receptors mediate nonvesicular transporter-dependent GABA release from rat striatal medium spiny neurons
56. Changes in extracellular levels of glutamate and aspartate in rat substantia nigra induced by dopamine receptor ligands: In vivo microdialysis studies
57. Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes
58. Involvement of dopamine and excitatory amino acid transmission in novelty-induced motor activity
59. Amphetamine depresses excitatory synaptic transmission via serotonin receptors in the ventral tegmental area
60. Regulation of phosphorylation of the GluR1 AMPA receptor in the neostriatum by dopamine and psychostimulants in vivo
61. Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine
62. Repeated administration of cocaine or amphetamine alters neuronal responses to glutamate in the mesoaccumbens dopamine system
63. Neurotransmitter regulation of dopamine neurons in the ventral tegmental area
64. Neurofilament proteins and the mesolimbic dopamine system: Common regulation by chronic morphine and chronic cocaine in the rat ventral tegmental area
65. Dissociation of the effects of amphetamine and quinpirole on dopamine release in the nucleus accumbens following behavioural sensitization: An ex vivo voltammetric study
66. Dopamine uptake is differentially regulated in rat striatum and nucleus accumbens
67. 3H]dopamine
68. Regulation of rat cortex function by D1 dopamine receptors in the striatum
69. Release-regulating D-2 dopamine receptors are located on striatal glutamatergic nerve terminals
70. Progressive augmentation of striatal and accumbal preprotachykinin mRNA levels by chronic treatment with methamphetamine and effect of concurrent administration of the N-methyl-D-aspartate receptor antagonist MK-801
71. Effects of tachykinins on dopamine release in the striatum: In vitro and in vivo studies
72. 3H]dopamine from rat striatal slices: A tetrodotoxin- sensitive process
73. Chemical anatomy of the brain
74. Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: Repeated administration
75. Cocaine and other stimulants. Actions, abuse, and treatment
76. The progressive changes of neuronal activities of the nigral dopaminergic neurons upon withdrawal from continuous infusion of cocaine